Regulatory T-cells have a prominent role in the immune modulated vaccine response by specific oligosaccharides

Vaccine

Volumn 28, Issue 35, 2010, Pages 5711-5717

  van't Land, Belinda ^a,b   Schijf, Marcel ^b,c   van Esch, Betty C A M ^a,b   van Bergenhenegouwen, Jeroen ^a,b   Bastiaans, Jacqueline ^b   Schouten, Bastiaan ^a   Boon, Louis ^d   Garssen, Johan ^a,b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b DANONE RESEARCH   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d BIOCEROS   (Netherlands)

Author keywords

Flu vaccination; Non digestible oligosaccharides; PC61; Regulatory T cells (Treg)

Indexed keywords

IMMUNOLOGICAL ADJUVANT; INFLUENZA VACCINE; OLIGOSACCHARIDE; PLACEBO; PREBIOTIC AGENT; SPECOL; STIMUNE; TRANSCRIPTION FACTOR T BET; UNCLASSIFIED DRUG; INTERLEUKIN 2 RECEPTOR ALPHA;

ANIMAL EXPERIMENT; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; DELAYED HYPERSENSITIVITY; IMMUNE RESPONSE; IMMUNOMODULATION; INFLUENZA; INFLUENZA VACCINATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TREATMENT RESPONSE; ANIMAL; C57BL MOUSE; GERMFREE ANIMAL; IMMUNOLOGY; ORTHOMYXOVIRIDAE INFECTIONS; SPLEEN;

ANIMALS; INFLUENZA VACCINES; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MALE; MICE; MICE, INBRED C57BL; OLIGOSACCHARIDES; ORTHOMYXOVIRIDAE INFECTIONS; PREBIOTICS; SPECIFIC PATHOGEN-FREE ORGANISMS; SPLEEN; T-LYMPHOCYTES, REGULATORY;

EID: 77955088496     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.06.046     Document Type: Article

References (26)

1. Kunisaki K.M., Janoff E.N. Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses. Lancet Infect Dis 2009, 9(8):493-504.
2. Vignali D.A., Collison L.W., Workman C.J. How regulatory T cells work. Nat Rev Immunol 2008, 8(7):523-532.
3. Shevach E.M., DiPaolo R.A., Andersson J., Zhao D.M., Stephens G.L., Thornton A.M. The lifestyle of naturally occurring CD4+CD25+Foxp3+ regulatory T cells. Immunol Rev 2006, 212:60-73.
4. Haribhai D., Lin W., Relland L.M., Truong N., Williams C.B., Chatila T.A. Regulatory T cells dynamically control the primary immune response to foreign antigen. J Immunol 2007, 17(8(5)):2961-2972.
5. Belkaid Y., Rouse B.T. Natural regulatory T cells in infectious disease. Nat Immunol 2005, 6(4):353-360.
6. Szabo S.J., Kim S.T., Costa G.L., Zhang X., Fathman C.G., Glimcher L.H. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 2000, 100(6):655-669.
7. Oldenhove G., de Heusch M., Urbain-Vansanten G., Urbain J., Maliszewski C., Leo O., et al. CD4+CD25+regulatory T cells control T helper cell type 1 responses to foreign antigens induced by mature dendritic cells in vivo. J Exp Med 2003, 198(2):259-266.
8. Sutmuller R.P., van Duivenvoorde L.M., van Elsas A., Schumacher T.N., Wildenberg M.E., Allison J.P., et al. Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses. J Exp Med 2001, 194(6):823-832.
9. Kohm A.P., McMahon J.S., Podojil J.R., Begolka W.S., DeGutes M., Kasprowicz D.J., et al. Cutting edge: anti-CD25 monoclonal antibody injection results in the functional inactivation, not depletion, of CD4+CD25+T regulatory cells. J Immunol 2006, 176(6):3301-3305.
10. Shimizu J., Yamazaki S., Sakaguchi S. Induction of tumor immunity by removing CD25+CD4+T cells: a common basis between tumor immunity and autoimmunity. J Immunol 1999, 163(10):5211-5218.
11. Lewkowich I.P., Herman N.S., Schleifer K.W., Dance M.P., Chan B.L., Dienger K.M., et al. CD4+CD25+T cells protect against experimentally induced asthma and alter pulmonary dendritic cell phenotype and function. J Exp Med 2005, 202(11):1549-1561.
12. Fecci P.E., Sweeney A.E., Grossi P.M., Nair S.K., Learn C.A., Mitchell D.A., et al. Systemic anti-CD25 monoclonal antibody administration safely enhances immunity in murine glioma without eliminating regulatory T cells. Clin Cancer Res 2006, 12(14 (Pt 1)):4294-4305.
13. McNeill A., Spittle E., Backstrom B.T. Partial depletion of CD69low-expressing natural regulatory T cells with the anti-CD25 monoclonal antibody PC61. Scand J Immunol 2007, 65(1):63-69.
14. Arslanoglu S., Moro G.E., Schmitt J., Tandoi L., Rizzardi S., Boehm G. Early dietary intervention with a mixture of prebiotic oligosaccharides reduces the incidence of allergic manifestations and infections during the first two years of life. J Nutr 2008, 138(6):1091-1095.
15. Vos A., M'Rabet L., Stahl B., Boehm G., Garssen J. Immune-modulatory effects and potential working mechanisms of orally applied nondigestible carbohydrates. Crit Rev Immunol 2007, 27(2):97-140.
16. Ishikawa H., Tanaka K., Maeda Y., Aiba Y., Hata A., Tsuji N.M., et al. Effect of intestinal microbiota on the induction of regulatory CD25+CD4+T cells. Clin Exp Immunol 2008, 153(1):127-135.
17. McHugh R.S., Shevach E.M. Cutting edge: depletion of CD4+CD25+regulatory T cells is necessary, but not sufficient, for induction of organ-specific autoimmune disease. J Immunol 2002, 168(12):5979-5983.
18. Taguchi O., Takahashi T. Administration of anti-interleukin-2 receptor alpha antibody in vivo induces localized autoimmune disease. Eur J Immunol 1996, 26(7):1608-1612.
19. Billiard F., Litvinova E., Saadoun D., Djelti F., Klatzmann D., Cohen J.L., et al. Regulatory and effector T cell activation levels are prime determinants of in vivo immune regulation. J Immunol 2006, 177(4):2167-2174.
20. van Wijk F., Nierkens S., de Jong W., Wehrens E.J., Boon L., van Kooten P., et al. The CD28/CTLA-4-B7 signaling pathway is involved in both allergic sensitization and tolerance induction to orally administered peanut proteins. J Immunol 2007, 178(11):6894-6900.
21. Vos A.P., Haarman M., Buco A., Govers M., Knol J., Garssen J., et al. A specific prebiotic oligosaccharide mixture stimulates delayed-type hypersensitivity in a murine influenza vaccination model. Int Immunopharmacol 2006, 6(8):1277-1286.
22. Tang Q., Bluestone J.A. The Foxp3+ regulatory T cell: a jack of all trades, master of regulation. Nat Immunol 2008, 9(3):239-244.
23. Pandiyan P., Zheng L., Ishihara S., Reed J., Lenardo M.J. CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells. Nat Immunol 2007, 8(12):1353-1362.
24. Romagnani S. Immunologic influences on allergy and the TH1/TH2 balance. J Allergy Clin Immunol 2004, 113(3):395-400.
25. Koch M.A., Tucker-Heard G., Perdue N.R., Killebrew J.R., Urdahl K.B., Campbell D.J. The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat Immunol 2009, 10(6):595-602.
26. Zheng Y., Chaudhry A., Kas A., de Roos P., Kim J.M., Chu T.T., et al. Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses. Nature 2009, 458(7236):351-356.